ArticleTranslational lung cancer research2025

Novel immune checkpoint inhibitor strategies in advanced non-small cell lung cancer: towards biomarker-driven therapies?

M Benthe Muntinghe-Wagenaar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.